XML 65 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [line items]  
Summary of acquisitions completed during the years

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 2021

Purchase price allocation

​

EMMAC (2)

Grassroots Maryland (2)

Ohio Grown Therapies (1)

​

Los Sueños Farms, LLC (2)

Assets acquired:

​

​

​

​

​

​

​

​

​

Cash

​

$

1,490

$

11,976

$

—

$

1,025

Accounts receivable, net

​

​

19,318

​

2,424

​

—

​

763

Prepaid expenses and other current assets

​

​

—

​

66

​

—

​

38

Inventory

​

​

3,826

​

4,550

​

—

​

1,601

Biological assets

​

​

472

​

1,164

​

—

​

11,232

Property, plant and equipment, net

​

​

7,549

​

19,448

​

—

​

8,975

Right-of-use assets

​

​

4,360

​

726

​

—

​

2,043

Other assets

​

​

1,801

​

689

​

—

​

20

Intangible assets:

​

​

​

​

​

​

​

​

​

Licenses

​

​

228,446

​

112,460

​

20,000

​

1,200

Trade name

​

​

11,156

​

—

​

—

​

—

Non-compete agreements

​

​

3,294

​

—

​

—

​

140

Know How

​

​

114

​

—

​

—

​

3,020

Customer List

​

​

—

​

—

​

—

​

500

Goodwill

​

​

61,806

​

20,346

​

—

​

29,299

Deferred tax liabilities

​

​

(48,910)

​

(33,235)

​

—

​

—

Liabilities assumed

​

​

(27,171)

​

(8,382)

​

—

​

(3,696)

Consideration transferred

​

$

267,551

$

132,232

$

20,000

$

56,160

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 2020

Purchase price allocation

​

Cura (2)
(As Restated)

Remedy (2)

Arrow (1)

MEOT (2)

Curaleaf NJ (2)

Blue Kudu (1)

Grassroots (2)

ATG (2)

Assets acquired:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash

​

$

12,755

$

172

$

711

$

395

$

3,667

$

276

$

29,624

$

7,253

Accounts receivable, net

​

​

11,027

​

15

​

—

​

129

​

1,995

​

350

​

5,486

​

—

Prepaid expenses and other current assets

​

​

2,232

​

3

​

—

​

15

​

405

​

—

​

5,675

​

787

Inventory

​

​

22,074

​

227

​

508

​

1,418

​

4,962

​

123

​

13,174

​

3,455

Biological assets

​

​

—

​

79

​

—

​

705

​

2,340

​

—

​

4,571

​

379

Property, plant and equipment, net

​

​

7,465

​

319

​

1,854

​

1,081

​

6,187

​

56

​

40,348

​

4,397

Right-of-use assets

​

​

9,047

​

108

​

2,058

​

1,812

​

41,518

​

812

​

114,665

​

1,555

Other assets

​

​

832

​

—

​

—

​

1,034

​

46

​

—

​

20,842

​

—

Intangible assets:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Licenses

​

​

640

​

—

​

38,435

​

—

​

57,580

​

3,845

​

353,529

​

24,690

Trade name

​

​

122,640

​

160

​

—

​

170

​

8,260

​

—

​

12,130

​

120

Service agreements

​

​

—

​

1,430

​

—

​

5,830

​

—

​

—

​

3,080

​

—

Non-compete agreements

​

​

5,580

​

—

​

—

​

—

​

—

​

—

​

19,290

​

—

Goodwill

​

​

181,933

​

909

​

—

​

561

​

22,863

​

—

​

213,803

​

19,072

Deferred tax liabilities

​

​

(29,132)

​

(480)

​

—

​

(1,680)

​

(20,525)

​

—

​

(117,720)

​

(9,397)

Liabilities assumed

​

​

(22,652)

​

(573)

​

(5,885)

​

(3,426)

​

(46,065)

​

(1,469)

​

(163,311)

​

(9,811)

Consideration transferred

​

$

324,441

$

2,369

$

37,681

$

8,044

$

83,233

$

3,993

$

555,186

$

42,500

(1)Acquisition accounted for as an asset acquisition with the application of the IFRS 3 Amendment.
(2)Acquisition accounted for as a business combination under IFRS 3.